InvestorsHub Logo
icon url

postes

09/25/20 9:52 AM

#301482 RE: Invest83838 #301477

You would think that 800 sales reps would have the skills with the wonder drug Vascepa which is not even in the same ballpark as Lovassa to educate dr's and the tide would have turned by now.
icon url

rosemountbomber

09/25/20 10:05 AM

#301492 RE: Invest83838 #301477

Yep, I don't know why we are so worried about Generic V cos selling into the R-I indication when we can't even stop a completely different drug (gen L) from selling into R-I indication. Because the sales volume for gen L is not strictly for trigs over 500.
icon url

Babr

09/25/20 10:21 AM

#301493 RE: Invest83838 #301477

Doctors are still not educated on the use of vascepa, they are treating elevated triglycerides but still with the wrong medications , I don’t even know if they treat for reduce it indication yet marketing has not been effective.
I guess the state of medicine is as bad as the legal system.